INTEGRA DERMAL REGENERATION TEMPLATE
Integra Lifesciences Corp. · Decision date Mar 1, 1996
What did the FDA approve?
FDA records P900033 as an original PMA application. The recorded decision is approval, dated Mar 1, 1996.
FDA approval order statement
APPROVAL FOR THE INTEGRA ARTIFICAL SKIN
- Regulatory pathway
- Original PMA
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Mar 1, 1996
Regulatory record facts
- Identifier
- P900033
- Regulatory pathway
- Premarket approval application
- Applicant
- Integra Lifesciences Corp.
- Product code
- MGR
- Decision code
- APPR
- Decision date
- Mar 1, 1996
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Dressing, wound and burn, interactive.
- Applicant
- Integra Lifesciences Corp.
- Product code
- MGR
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P900033 received
Application receipt date recorded by FDA.
P900033 · FDA decision
APPR
P900033/S117 · Related supplement
INTEGRA Dermal Regeneration Template, Integra Meshed Dermal Regeneration Template, and Integra Omnigraft Dermal Rege
Timeline entries are records held by MedtechLedger for P900033. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P900033
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Integra Lifesciences Corp. | PMA supplement | Sep 18, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Integra Lifesciences Corp.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 105 Morgan Ln., Plainsboro, NJ, 08536
Sources and methodology
- Original FDA record: P900033
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records